IDNA vs IVV
iShares Genomics Immunology and Healthcare ETF vs iShares Core S&P 500 ETF
Which is better, IDNA or IVV?
Mid Cap Growth against Large Cap Blend.
IVV has a lower expense ratio. IDNA led over 1Y and 3Y, IVV over 5Y and the full window. IVV is less concentrated, with 37.9% of the fund in its ten largest positions against 43.5%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | IDNA | IVV |
|---|---|---|
| Expense Ratio | 0.47% | 0.03%Best |
| AUM | $257M | $886.7B |
| Dividend Yield | 0.86% | 1.10% |
| Holdings | 62 | 508 |
| YTD Return | +52.32%Best | +13.39% |
| 1Y Return | +78.00%Best | +20.08% |
| 3Y Return (annualized) | +22.29%Best | +21.29% |
| 5Y Return (annualized) | -5.36% | +12.88%Best |
| Volatility (annualized) | 26.0% | 16.4%Best |
| Max Drawdown | -68.3% | -33.9%Best |
| $10,000 over 5 years | $7,592 | $18,327Best |
| Top 10 Weight | 43.5% | 37.9%Best |
| Fund Family | iShares by BlackRock (US) | iShares by BlackRock (US) |
| Category | Equity | Equity |
| Style | Mid Cap Growth | Large Cap Blend |
| Inception | Jun 11, 2019 | May 15, 2000 |
Volatility and max drawdown are measured over the window both funds cover: Jun 13, 2019 to Sep 4, 2026 (7.2 years).
IDNA vs IVV growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 7.2 years both funds cover.
IDNA vs IVV Performance
iShares Genomics Immunology and Healthcare ETF (IDNA) is an ETF from iShares by BlackRock (US) and iShares Core S&P 500 ETF (IVV) is an ETF from iShares by BlackRock (US). Over the past year IDNA returned +78.00% while IVV returned +20.08%. Year to date, IDNA is up 52.32% versus a gain of 13.39% for IVV.
Over three years, IDNA compounded at +22.29% per year against +21.29% for IVV; over five years the annualized figures are -5.36% and +12.88% respectively. Across the full 7-year window we track, IVV has the edge at +15.68% annualized vs +7.40%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
IDNA has been the more volatile fund, with annualized monthly volatility of 26.0% compared with 16.4% for IVV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -68.3% for IDNA and -33.9% for IVV. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.57. They move together some of the time, and apart the rest.
Fees and Cost Over Time
IDNA charges 0.47% per year while IVV charges 0.03%. On a $10,000 position that is $47 vs $3 annually, a gap of $44 per year that compounds over a long holding period. On income, IDNA currently yields 0.86% against 1.10% for IVV.
Holdings Overlap
24.1% of IDNA's money is in holdings IVV also owns. 1.3% of IVV's money is in holdings IDNA also owns.
IDNA and IVV share little of their money.
8 positions in common, counted across the 50 positions we hold weights for in IDNA and 505 in IVV, against full books of 62 and 508.
What only one of them owns
Our book lists 489 positions for IVV that do not appear in our book for IDNA (98.0% of the fund), and 25 for IDNA that do not appear in IVV (40.5%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in IDNA | Weight in IVV | Difference |
|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | 4.26% | 0.12% | 4.14% |
| MRKMerck & Company Inc | 3.74% | 0.48% | 3.26% |
| MRNAModerna therapeutics | 4.18% | 0.03% | 4.15% |
| INCYIncyte Corp. | 4.12% | 0.03% | 4.09% |
| VRTXNvaesrtex Pharmaceuticals Inc | 3.82% | 0.18% | 3.64% |
| ROPRoper Technologies Inc. | 3.86% | 0.06% | 3.80% |
| XTSLABlackrock Cash Funds: Treasury, Sl Agency Shares | 0.09% | 0.18% | 0.09% |
| GILDGilead Sciences Inc | 0.00% | 0.25% | 0.25% |
24.1% of IDNA is already inside IVV.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, IDNA or IVV?
IDNA has an expense ratio of 0.47% while IVV charges 0.03%. IVV is the cheaper option, by $44 a year on a $10,000 investment.
Which performed better, IDNA or IVV?
Over the past year IDNA returned +78.00% vs +20.08% for IVV, so IDNA leads on 1-year performance. Over the longest common window we track (7 years), IDNA annualized +7.40% vs +15.68% for IVV. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, IDNA or IVV?
IDNA has been the more volatile fund at 26.0% annualized versus 16.4% for IVV. Worst drawdown: IDNA -68.3% vs IVV -33.9%.
Should I hold both IDNA and IVV?
IDNA and IVV have a monthly-return correlation of 0.57, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between IDNA and IVV?
24.1% of IDNA's money is in holdings IVV also owns. 1.3% of IVV's is in holdings IDNA also owns. They hold 8 positions in common, counted across the 50 positions we hold weights for in IDNA and 505 in IVV.
Which pays a higher dividend, IDNA or IVV?
IDNA yields 0.86% while IVV yields 1.10%, so IVV currently pays the higher dividend yield.
Is IVV better than IDNA?
IVV has a lower expense ratio. IDNA led over 1Y and 3Y, IVV over 5Y and the full window. IVV is less concentrated, with 37.9% of the fund in its ten largest positions against 43.5%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.